BioSpace News Archive

Vaxxinity, Inc. announced it will present clinical data from its UB-312 program in Parkinson’s disease at the Annual Academy of Neurology 2024 Annual Meeting, taking place April 13-18, 2024 virtually and in Denver, Colorado.

RefleXion Medical, Inc. and Limbus AI, Inc. announced a licensing agreement to incorporate Limbus’ automated contouring software, Limbus Contour, into the RefleXion® X1 radiotherapy treatment planning system.

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2023 annual results as of 31 December 2023.

Vaccines are one of the most significant public health achievements in modern history, playing a vital role in helping to prevent certain infectious diseases and protect communities across the globe.

Tonix Pharmaceuticals Holding Corp. announced it has entered into a securities purchase agreement with existing healthcare focused institutional investors of the Company for the purchase and sale of 14,666,666 shares of its common stock and warrants to purchase up to an aggregate of 14,666,666 shares of common stock in a registered direct offering at a combined offering price of $0.30 per share and accompanying warrant.

Serum Detect, a cancer diagnostics company, is debuting a novel and promising approach for cancer early detection at the upcoming American Association for Cancer Research (AACR) conference.

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”) today announces that the company will be utilizing the preclinical services program offered by the National Institute of Allergy and Infectious Diseases (NIAID) to evaluate RLS-0071 as a medical countermeasure for Acute Radiation Syndrome (ARS).

Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with cell therapy, today announced that The Lancet published the company’s pivotal Phase 2 data with afami-cel.

Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) announced that additional data from the ABACUS-1 trial has been accepted for presentation at the Association for Research in Vision

Nikon Instruments Inc. is pleased to announce that they have entered into a partnership with Lunaphore, part of Bio-Techne Corporation’s Spatial Biology Division, to expand access to spatial biology services with the COMET™ platform for US-based biotech, pharma, and academic customers.